Related Experiment Video

Updated: Aug 22, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a

C Michael Gibson1, Kanwar P Singh, Sabina A Murphy

  • 1Department of Medicine, Brigham & Women's Hospital, 350 Longwood Avenue, Boston, MA 02115, USA. mgibson@timi.org

The American Journal of Cardiology
|August 25, 2004
PubMed

Insights

Shorter tirofiban infusions before percutaneous coronary intervention in acute coronary syndromes may worsen myocardial perfusion. This finding impacts treatment strategies for patients with acute coronary syndromes undergoing invasive procedures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Pharmacology

Background:

  • Acute coronary syndromes involve platelet activation and thrombotic embolization.
  • Vasoconstrictors released into microvasculature can impair blood flow.
  • Early intervention aims to restore myocardial perfusion.

Purpose of the Study:

  • To investigate the impact of tirofiban infusion duration on myocardial perfusion.
  • To analyze outcomes from the TACTICS-TIMI 18 trial angiographic substudy.

Main Methods:

  • Analysis of data from the TACTICS-TIMI 18 trial.
  • Focus on an angiographic substudy examining myocardial perfusion.
  • Correlation of tirofiban infusion duration with perfusion before and after intervention.

Main Results:

  • A shorter duration of tirofiban infusion was linked to poorer myocardial perfusion.
  • Impaired perfusion was observed both before and after percutaneous coronary intervention.

Conclusions:

  • Optimizing tirofiban infusion duration is crucial for improving outcomes in acute coronary syndromes.
  • Findings suggest a need for careful consideration of pre-procedural antiplatelet therapy duration.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...